Can guidelines to increase appropriate health care, usually done at the national level, be developed at an international level? Two panels of experienced urologists used a modified Delphi process to rate 1152 indications for the most common treatments for BPH on a nine-point scale.
We need valid measures for assessing quality of care for prostate cancer, and we need to understand how variations in quality of care affect treatment outcomes. RAND researchers have built the framework necessary to begin this evaluation.
The authors compare general and disease specific health related quality of life in men undergoing brachytherapy for early stage prostate cancer to those undergoing radical prostatectomy and age matched healthy controls.